Hyperfine Inc (HYPR) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Medical Devices industry.
Over the past 4 years, Hyperfine Inc has achieved a revenue compound annual growth rate (CAGR) of 157.3%, while earnings have grown at 14.8% CAGR.
Historical revenue and profitability trends for Hyperfine Inc
The chart above illustrates Hyperfine Inc's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Hyperfine Inc's business.
How efficiently Hyperfine Inc converts revenue into profit
Profit margins reveal how much of each dollar of revenue Hyperfine Inc retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Hyperfine Inc to continue growing earnings in the coming year. The consensus analyst rating is 4 based on 4 analysts.
Based on our comprehensive analysis, Hyperfine Inc (HYPR) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Hyperfine Inc's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Hyperfine Inc stacks up against similar companies
Explore growth analysis for top stocks
Related: HYPR Valuation, HYPR Dividend, HYPR Financial Health
Compare: HYPR vs AAPL, HYPR vs MSFT, HYPR vs GOOGL